Skylark Bio Inc.: Clinical Trials

1 trial sponsored by Skylark Bio Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Skylark Bio Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss
SKY-GJB2 - GJB2-mediated Hearing Loss, GJB2 Gene Mutation
Phase 1 / Phase 2RecruitingSkylark Bio Inc.102026-05-282026-08-27

Conditions studied

Deafness (1)  ·  Deafness, Autosomal Recessive 1A (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Bilateral (1)  ·  Hearing Loss, Sensorineural (1)

Countries

United States (1)